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Abstract
The implantable cardioverter defibrillator (lCD) is the most effective
treatment available for terminating potentially life-threatening ventricular
fibrillation and ventricular tachycardia. The lCD detects and attempts to correct
these arrhythmias by pacing, cardioversion, and defibrillation thereby providing
lifesaving therapy to patients at risk for sudden cardiac death. Currently, 150,000
Americans receive ICDs each year. Although most lCD recipients are men, more
women are now qualifying for insertion (Stutts, Cross, Conti, & Sears, 2007).
Despite its established health benefits, lCD implantation is accompanied
by psychological factors which merit research attention. This study investigated
the experiences of women who live an lCD. The homogenous, purposeful
sample consisted of 15 women who had an lCD that was implanted within the
last three years and were receiving follow-up treatment at the same north Florida
clinic. Data collection was accomplished through a semi-structured interview
specific to the areas of pre-implantation, immediate post-implantation, and
discharge home. Results were transcribed verbatim and then analyzed. Five core
themes emerged from the transcripts along with multiple subcategories. The
main themes included: Psychological Reactions, Physical Comfort, Procedural
Issues, Body Image, and Feelings Regarding a Shock. Information obtained from
this research is beneficial to nurses providing care to women with ICDs and to
primary care advanced nurse practitioners in order to improve the overall health
outcome and ongoing care of these women.

Chapter I
Introduction
Sudden cardiac death (SCD) takes thousands of lives in the United States
each year. The usual cause of SCD is an unstable, fast ventricular rhythm.
Ventricular tachycardia (VT) and ventricular fibrillation (VF) are the two
arrhythmias that cause most of these deaths. When either arrhythmia occurs, the
heart cannot pump enough blood throughout the body. Unless treatment is
delivered within a few minutes, death is eminent. Long-term treatment options for
people who survive life-threatening ventricular rhythms include medications,
surgery, the implantable cardioverter defibrillator (lCD), or combination of
treatments. ICDs are devices that sense these life-threatening arrhythmias
automatically and deliver electrical therapy or lifesaving shock directly to the
myocardium (Chen, Wu, & Ting, 2003).
Indicators for treatment with an implantable cardioverter-defibrillator (lCD)
are expanding allowing more patients to qualify for its insertion. According to the
2008 American College of Cardiology/American Heart Association guidelines,
basic criteria that are required before consideration of lCD therapy include; prior
episode of resuscitated VT and/or VF after exclusion of completely reversible
causes, left ventricular dysfunction due to a prior myocardial infarction (MI) that
occurred at least 40 days ago, hypertrophic cardiomyopathy, optimization of
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medical therapy, and expected survival with a good functional status of at least
one year (Association for Thoracic Surgery, Society of Thoracic Surgeons, 2008).
Approximately 150,000 people in the United States receive ICDs each year
(Stutts, Cross, Conti, & Sears, 2007). Patient reaction to the lCD has been an
area of interest for researchers since its approval in 1985 (Sola & Bostwick,
2005). In general, most studies have suggested that implantation and activation
of the lCD can cause adverse psychological impact on patients. However, since
recipients of an lCD thus far have been mostly men, study participants have
coincidentally been mostly men. In research that was inclusive of women, the
ratio on average was four to one, men to women respectively.
The occurrence of ICD-specific fears and symptoms of anxiety are
common psychological symptoms experienced by lCD recipients. These patients
must cope with the prospect of life-threatening arrhythmias, rely on the device for
the precise delivery of therapy, and live with the potential for the lCD shock. They
may experience excessive worry and physiological arousal; in fact up to 38%
have diagnosable anxiety. Other negative moods, notably anger, also increased
after lCD implantation and were highest at the time of implantation (Carroll &
Hamilton, 2008). The shock experience, device malfunction, and death are
common ICD-specific fears of patients documented in previous research studies
(Sears & Conti, 2006).

Purpose
The purpose of this study was to describe the experiences of women who
live with an lCD. Study findings will be used to better represent women's issues
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caused by their lCD implantation which will aid in better preparation and
treatment of such concerns by health care providers. Responses to women's lCD
implantation is relevant to nurses since they often prepare patients for this
experience and are often the first to hear of patients' unpleasant symptoms.
The framework for this research was based on the theory of unpleasant
symptoms (TOUS). Implantation of an lCD may subsequently cause a variety of
symptoms unique to women which are necessary to recognize. The TOUS,
which is discussed further in Chapter II, focuses on multiple symptoms that
coincide and relate to one another. According to this theory, additional symptoms
are more likely to impair cognitive and functional performance. However, when
one symptom is addressed, others become managed in the process (Gift, 2004 ).
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Chapter II
Literature Review
This chapter will provide an overview of cardiovascular disease, its
prevalence in the United States (US), and the underlying pathophysiology
leading into coronary artery disease in general, with particular emphasis on
sudden cardiac death (SCD). This will be followed by a brief discussion of the
various treatments of cardiovascular and coronary artery disease with a focus on
implantable cardioverter defibrillators (lCD) for the prevention of SCD. Finally, a
review of the available evidence with respect to the patient's physical and
psychological responses to the implantation of a cardioverter-defibrillator will be
presented.
Cardiovascular Disease in the United States
Cardiovascular disease (CVD) is the leading cause of death in the United
States. It is defined as any abnormal condition characterized by dysfunction of
the heart and blood vessels. CVD is common in the general population affecting
the majority of adults after 60 years of age. A substantial part of CVD progresses
abruptly from asymptomatic disease to coronary events such as angina pectoris
(chest pain/pressure/discomfort), heart failure (left ventricular dysfunction),
cerebrovascular accident (stroke/brain attack), and death. Premature mortality
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occurs primarily in the part of the population that has more modifiable risk factors
(Greenland, Knoll, & Stamler, 2003).
Age and gender differences are prevalent in CVD. For persons over 40
years of age, the lifetime risk of developing CVD is 49% in men and 32% in
women. For those reaching 70 years, the lifetime risk is 35% in men and 24% in
women. For total coronary events, incidence increases steeply with age, with
women lagging behind men by 10 years. For the more serious manifestations of
CVD such as myocardial infarction (MI) and SCD, women lag behind men in
incidence by 20 years. Beyond menopause, the incidence and severity of CVD
increases abruptly, with rates three times those of women the same age who
remain premenopausal (Eckel, York, & Rossner, 2004).
Cardiovascular disease as a diagnostic category includes four major
areas. One is aortic atherosclerosis and thoracic or abdominal aortic aneurysm.
A second is peripheral vascular disease manifested by intermittent claudication
and a third is cerebrovascular disease manifested by cerebrovascular accident
and transient ischemic attack. The fourth category, coronary artery disease
(CAD) which is manifested by Ml, angina pectoris, heart failure, and cardiac
death will be discussed (Eckel, York, & Rossner, 2004).

Coronary Artery Disease
Coronary artery disease is an abnormal condition that may affect the
heart's arteries producing various pathologic effects, especially the reduced flow
of oxygen and nutrients to the myocardium. The most common cause of CAD is
atherosclerosis, which is the formation of plaque within a hardened arterial wall.
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CAD can diminish the myocardium's blood supply until it causes ischemia, where
the myocardium's cells remain alive but cannot function normally. Persistent
ischemia or complete occlusion of a coronary artery causes infarction, or death of
the deprived myocardial tissues. Risk factors for the development of CAD include
age, genetics, male gender, dyslipidemia, hypertension, cigarette smoking,
diabetes mellitus, obesity/sedentary lifestyle, increased serum markers for
inflammation and thrombosis, hyperhomocysteinemia, and infection (McCance &
Huether, 2006).
CAD often results in myocardial infarction (MI). This occurs when coronary
blood flow is interrupted for an extended period of time. Cardiac cells can
withstand ischemic conditions for approximately 20 minutes before cellular death
occurs and is followed by tissue necrosis. Structural changes post Ml lead to
functional irregularities such as decreased cardiac contractility with abnormal wall
motion, altered left ventricular compliance, deceased stroke volume and ejection
fraction, increased left ventricular end-diastolic pressure, and sinoatrial node
malfunction. All of these transformations in combination or unaided often lead to
heart failure and life-threatening arrhythmias (McCance & Huether, 2006).
Arrhythmias are disturbances of cardiac rhythm and affect more than 90%
of individuals post Ml making them the most common complication of MI.
Arrhythmias range in severity from occasional "missed" or rapid beats to serious
disturbances that impair the pumping ability of the heart, all contributing to heart
failure and death (McCance & Huether, 2006). For example, atrial fibrillation
(AF) is the disorganized electrical activity in the atria characterized by quivering
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instead of pumping in an organized fashion (Chen et al., 2003). However, since
AF does not affect ventricular contraction, it can be tolerated by most individuals
(McCance & Huether). In contrast, a serious arrhythmia that can develop is
ventricular tachycardia (VT) which consists of at least three consecutive
ventricular complexes with a rate greater than 100 per minute. VT often may lead
to ventricular fibrillation (VF) which occurs when the ventricles quiver very rapidly
and beat irregularly instead of in an organized fashion. VF allows little or no
blood to the body and death occurs if not treated with electrical defibrillation
within minutes (National Heart Lung and Blood Institute [NLHBI], 2006).
Patients post Ml are at risk for life-threatening arrhythmias which may lead
to an unexpected death. When cardiac arrest or cardiac death occurs in this
manner, it is termed SCD. This phrase is used to describe cardiac arrest with
cessation of cardiac function, whether or not resuscitation or spontaneous
reversion occurs; a misleading definition since not all affected individuals actually
die (Pires, Lehman, & Steinman, 1999). The World Health Organization
developed a clinical definition of SCD as the sudden collapse occurring within
one hour of symptoms. However, as implied by the name, SCD is instantaneous
and most individuals become unconscious within seconds to minutes as a result
of insufficient cerebral blood flow. There usually are no premonitory symptoms. If
symptoms are present, they are nonspecific and include chest discomfort,
palpitations, shortness of breath, and weakness. Each year, between 250,000
and 450,000 Americans experience SCD, and 95% of them do die within
minutes. SCD occurs most often in adults in their mid-thirties to mid-forties and
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affects men twice as often as women. Treatment of SCD consists of acute
resuscitation with electrical defibrillation of most importance followed by longterm prevention of recurrence by pharmacological and nonpharmacological
means (NHLBI, 2006).

Treatment of Coronary Artery Disease
Risk reduction is a key component of treatment of coronary artery disease.
Three risk factors about which the most effort should be made to correct are
hypertension, cigarette smoking, and blood lipid abnormalities. Control of these
can significantly reduce the risk of CAD. In addition, control of diabetes mellitus is
extremely important. Obesity and physical inactivity should be approached in
correspondence with lipid reduction. Exercise is important for weight reduction
and regulation of lipids (Edmunds & Mayhew, 2004 ).
Various pharmacologic treatments of CAD are available. For angina
pectoris, nitrates are often used. Beta-adrenergic blockers and angiotensinconverting enzyme inhibitors or angiotensin II receptor blockers are prescribed
for hypertension and systolic dysfunction management. Antihyperlipidemic
agents are used to aid in dyslipidemia. Aspirin or other antiplatelet
agenUanticoagulants are used to aid in anti-thrombus formation (Edmunds &
Mayhew, 2004 ).
Patients with arrhythmias can also be treated with medications. In AF,
patients must remain anticoagulated with aspirin or warfarin. Non-dihydropyridine
calcium channel blockers, such as diltiazem, and beta-adrenergic blockers, such
as metoprolol offer control of the ventricular response seen with this arrhythmia.
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Occasionally, cardiac glycosides such as digoxin are added to decrease the
ventricular rate also. Patients with more serious arrhythmias, such as VT or VF
can be treated with antiarrythmic medications. The most common is the class Ill
antiarrythmic, amiodarone. Amiodarone is used both in emergency situations
such as during the sudden cardiac arrest and prophylactically for patients at risk
for lethal arrhythmias. Amiodarone does possess significant risks for adverse
events however. It carries a black box warning due to its variable absorption and
its prolonged elimination averaging 60 days. Patients using this medication are at
risk for pulmonary and/or hepatic toxicity. Opposite of its desired action, is
amiodarone's proarrhythmic effects including arrhythmia exacerbation, significant
heart block, or sinus bradycardia (Edmunds & Mayhew, 2004).
Alternatives to pharmacologic therapy are available for the treatment of
ventricular arrhythmias. Radiofrequency ablation can be an effective treatment
for AF and VT. Surgery and cardiac transplantation are also options for certain
arrhythmias. First line therapy for treatment of SCD is placement of an lCD since
it has proven more effective for improving survival than any other (Sola &
Bostwick, 2005).

/CD Functions and Components
An lCD can deliver life-saving electrical treatment and may be used to
help correct an arrhythmia. An lCD is a small electronic device implanted in the
body to monitor the heart continually. It functions as a pacemaker for slow heart
rates but when ventricular arrhythmias occur, it treats the rhythm with the specific
type of electrical therapy required. The three types of electrical therapy are:
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rapid-pacing, low-energy shock, and high-energy shock. Depending on patient
needs predetermined with results of an electrophysiology study, electrical
therapy is delivered via pacing, a shock, or a combination of the two. For
example, if VT occurs, the lCD may deliver small electrical pacing pulses to
correct the rhythm which the patient does not feel. If a normal rhythm is not
restored, the lCD will then deliver a shock. The lCD also records and saves
information about any therapy delivered which aids in discovering what occurred
during each episode (Mayo Clinic, 2005).
There are three elements of the lCD system: sensing electrodes,
defibrillation electrodes, and the pulse generator. Sensing (or the ability of the
lCD to "see" intrinsic activity) is accomplished by closely spaced tip and ring
electrodes that provide high amplitude narrow electrograms. These sensing
electrodes are positioned transvenously on the right ventricular apical
endocardium during implantation. The electrodes record normal beats that are
sufficiently large enough for analysis during ventricular tachycardia and
fibrillation. Dual chamber ICDs have an additional electrode in the right atrium for
atrial sensing and pacing. The defibrillation electrodes have a relatively large
surface area and are positioned to maximize the density of current through the
ventricular system. The lead systems utilize the "active can" technology in which
the metal housing of the lCD serves as one of the shocking electrodes, which
requires that the pulse generator be implanted in the pectoral region. The pulse
generator, which is about the size of a stopwatch, contains the sensing circuitry
as well as the high voltage capacitors and battery. After detecting a
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tachyarrhythmia, the pulse generator responds by antitachycardia pacing or by
delivering low- or high-energy shocks (Sola & Bostwick, 2005).

/CD Implantation
Traditional implantation of an lCD usually requires two incisions. Usually,
local anesthesia is administered to numb the area of the incisions and
intravenous sedation medication is used for relaxation and comfort. The lCD lead
systems are typically placed transvenously via the axillary, subclavian, or
cephalic vessel through a puncture in the skin. They are passed to the heart
using X-ray equipment to follow the progress, then are positioned and tested
before connection to the lCD. Proper functioning is tested by the physician
shocking the heart in such a way to create a fast ventricular rhythm. The patient
does not feel the arrhythmia or shock due to the general anesthesia administered
at this point. The pulse generator is then inserted through a 2-3 inch incision
created for a subpectoral or subfascial pocket in the left chest wall (a right sided
implant may be performed but is not preferred). The pocket incision is then
closed with subcutaneous sutures and steristrips (Mayo Clinic, 2005).
This particular placement type may pose more of a problem for women
specifically. Both visible scarring and bulging around the implant site are
produced by placement of the 78gram/40cm 3 device underneath the skin; a
location women's clothing often leaves exposed. The incision may be swollen
and red for weeks and after the puffiness subsides, the outline of the generator
and leads may be seen. The weight of the breast itself may pull and tear on
incision, making the scar larger still. Practical limitations of bra straps, purse
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straps, and seat belts may affect the female lCD implant recipient because of this
location (Sowell, Kuhl, Sears, Klodell, & Conti, 2006).

Immediate Post-Operative Care
After lCD implantation, nursing care is imperative. A pressure dressing
over the lCD incision site is applied for the first 12 hours in order to maintain the
integrity of the newly constructed body pocket. Hospitalization usually consists of
one overnight stay. Patients are on bed rest for two to six hours or until the
following morning in order to prevent slippage of the generator out of the
surgically formed pocket. Pain in the upper chest area incision may occur.
Patients are instructed to not raise the arm past shoulder height on the lCD side
for four weeks in order to avoid misplacing the leads. An arm sling is often
provided to discourage movement of the affected side's arm for the first postoperative day since ambulation is expected. Before discharge home, a chest Xray is taken to guarantee proper placement remains. The lCD is also interrogated
to ensure proper function and adjustments are made to settings if necessary
(Mayo Clinic, 2005).

Discharge Home
There are multiple instructions for patients discharged home after
immediate lCD implantation. Showering is permitted 48 hours post implant and
the steristrips may be removed in two weeks if still attached. Vigorous activities
or exercises that cause the arm to be stretched behind or raised above the
shoulder are prohibited for four weeks which allow formation of scar tissue
around the lead and lead anchors. Patients are encouraged to wear the sling at
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bedtime if they are likely to sleep with their arms over their head. Driving is
restricted until the health care provider allows. Since five to ten seconds pass
before the lCD senses the arrhythmia and provides a shock, patients may
become dizzy or lightheaded, which could endanger safety of all drivers (Mayo
Clinic, 2005). The time of the greatest risk for recurrent events is six months post
implant which is the normal driving restriction. However, once the lCD
discharges, the six-month driving restriction is reinstituted (Chen et al., 2003).
Activity and effects of electrical equipment on the lCD should be
addressed at discharge. Contact sports are prohibited since an impact can be
harmful to the lCD even after scar tissue formation. Airport security metal
detectors will not harm the lCD but may be activated by the device which is why
the lCD identification card should always be carried. Because of potential
interference, patients with ICDs must remain farther than eight feet from an arc
welder and also avoid powerful magnets and any heavy industrial equipment.
Most providers recommend cellular phones be kept at least six inches from the
lCD and on the opposite side. lCD recipients must not lean over a running engine
and can never have a magnetic resonance imaging (MRI) test (Mayo Clinic,
2005).
Indications for implantation of an lCD are expanding. The lCD is now
recommended not only for survivors of sustained VT and/or VF (due to
successful resuscitation) but for those at high risk for SCD. Generally stated,
patients who are at risk of developing ventricular arrhythmias, including heart
failure patients, qualify for an lCD. Increased indications for ICDs are a result of
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their proven superior outcomes compared to pharmacologic therapy.
Antiarrythmic medications help prevent ventricular arrhythmias but their
accompanied side effects and toxicity are of concern to patients and providers.
While an lCD will not prevent lethal ventricular rhythms, it will reverse them as
they occur without the previously described adverse effects of antiarrythmic
medications (Chen et al., 2003).
Evidence of Psychosocial Issues
Anxiety is a common finding amongst many studies concerning patients
with ICDs. A literature review performed by Sears and Conti (2002) surmised
that it is particularly common, with approximately 24-87% of lCD recipients
experiencing increased symptoms of anxiety after implantation with up to 38% of
patients eligible for a clinical diagnosis of anxiety. They stated that as long as the
lCD is seen as a "shock box," it will remain a significant source of anxiety. They
also found it likely that lCD recipients will need an amount of psychological
adjustment evidenced by 9-15% of patients having clinically diagnosed
depression. Another researcher, Dunbar analyzed transcripts of stories told by
lCD patients from her previous phenomenological studies in order to obtain a
description of the experience of living with an lCD after a sudden cardiac death
(2005). Three themes that emerged, and essentially led to the constitutive
summary of redefining life while forestalling death were; 1. losing control:
technology as lifesaving yet changing everything,

2. getting on with living,

regaining control or conditional acceptance, and 3. creating a new vision,
transformation or tenuous truce. Both studies' researchers suggested routine
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consideration of psychosocial needs as part of the clinical care of lCD patients.
They further recommended that advice measurement and interventions should
focus on patient acceptance of the device.
The personal impact of the device on families and/or partners of recipients
emerged from previous studies. In 2004, Albarran, Tagney, and James
performed an exploratory qualitative study with interviews of eight partners of
lCD patients; six wives and two husbands. Through their findings, they
suggested that partners of lCD recipients progress slowly through various difficult
and adaptive stages when learning how to best support the patient. Partners start
by acknowledging the patient's need for the lCD, then reacting to it. The partners
then tend to safeguard the patient; finally reaching the point when they are able
to assume control and normalize their lives. Carroll (2006) conducted a
descriptive qualitative study with ten men and two women in an attempt to
discover their experiences of returning to sexual activity after lCD insertion.
Results of semistructured interviews suggested that patients with ICDs
approached sexual activity with anxiety, apprehension, and varied amounts of
interest and patterns of activity. All participants expressed a need for more
information and sexual counseling. The anxiety of the partners of lCD patients in
this study also often resulted in overprotectiveness of the patient with the lCD.
In addition to discovering studies which validate psychosocial issues of
patients with ICDs, causation of these issues and aid in extinguishing them also
surfaced from the literature review. A randomized, controlled, prospective study
in the UK investigated the effects of a 12 week comprehensive cardiac
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rehabilitation (CCR) program on patients with an lCD. Participants included 14
men and 2 women. CCR appeared not only safe, but it improved exercising
ability thereby lowering levels of psychological distress. Researchers therefore
proposed that CCR reduces levels of anxiety and depression of patients with an
lCD (Fitchett et al., 2003). Also, Tagney (2004) explored the confidence and
competence of nurses in preparing patients for insertion of an lCD and for home
life post discharge. She used questionnaires on 152 cardiology-associated
nurses as her method and sample. Results of her study suggested that nurses
were not confident in their ability to prepare these patients. Therefore, educating
the nursing staff for pre-implantation and prescribing CCR post-implantation may
pose solutions to decreasing the number of psychosocial issues of patients with
ICDs.
Less Evidence of Psychosocial Issues
While performing this literature review, some research findings
contradicted the idea that patients with an lCD experience psychosocial issues.
While the majority of research pointed to a psychological problem, some were
not so clear.
A recent cross-sectional correlational design study that included 46
women of the total 174 subjects investigated quality of life, mood states, and
global adjustment after lCD implantation. Researchers found four subscales;
fear/anxiety, attitude, preparation, and body awareness. Perceived adjustment
was good for the majority of participants and was unrelated to sex, age, and
shock experience. They witnessed no gender differences, but noted disparity in
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body awareness, physical functioning, and fatigue (Beery, Baas, & Henthorn,
2007).
Two different groups of researchers in the UK performed two literature
reviews in order to investigate psychological impacts of lCD implant on patients.
Both reviews concluded that psychological problems probably result more from
the underlying disease instead of the direct response to the implant itself. The
meta-analytic review of 20 studies was conducted at a time when more patients
were being treated with medication instead of the lCD and so reported no
significant differences in the psychosocial outcome between lCD patients and
medication-maintained patients or between pre- and post- implant lCD recipients.
Researchers pointed out that lCD recipients did report significantly worse
psychological and psychosocial functioning than other cardiac controls (Burke,
Hallas, Clark-Carter, White, & Connelly, 2005). The other team paraphrased data
from a large randomized trial by suggesting," ... lCD therapy is neutral or possibly
beneficial with regard to QOL and patients can expect to feel as well [or as
poorly] as they did prior to implantation" (McCready & Exner, 2003, p. 68). The
researchers from this literature review admitted that lCD patients are at risk for
adverse psychological symptoms and poor quality of life (QOL) but rarely in
direct response to the lCD itself.
Additional contradiction to development of mental concerns of patients
with ICDs was suggested by another pair of research teams who both performed
studies concerning changes over time pertaining to quality of life (QOL) and other
psychologic issues. One study's researchers used a QOL index and Mishel's
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Uncertainty in Illness Scale. Results of their study were that the overall QOL and
health/functioning of patients with an lCD were unchanged over time. They did
point out that the first year post implantation was the most stressful and uncertain
time since this was before the patients had accepted and adapted to their
changed situation. The researchers' overall suggestion was that QOL for most
patients with an lCD was reasonably good after implantation once they had
passed the first year post implant (Fiemme et al., 2005). The other research team
utilized a prospective, descriptive, repeated, measures design which consisted of
questionnaires completed by 19 females and 51 males. They investigated
changes in perception of health status, psychological distress, and QOL from
baseline to six months, and then 12 months post implantation. Researchers
found no significant changes in the physical and mental health composite
summary scores over the first year. The authors claim their study identified an
improvement in psychological distress over time with a reduction in negative
psychological distress from baseline to six months. They recommended further
research since they confess, " ... the effects of lCD living are not well understood"
(Carrol, Hamilton, & Kenney, 2002, p. 213).
Despite nonsupporting evidence of psychosocial issues in patients with an
lCD in this section, all researchers recommend further research. None of the
four projects discussed were clear and concise. The fact that the majority were
all foreign and not very current should be considered.
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Increased Stress, Risk, and Lack of Women Subjects
Some study results' dismissal of the idea that patients with an lCD have
psychological issues might give justification to cease research pertaining to it.
However, all studies discussed thus far have had an unequal representation of
women versus men as participants. Also, research has proposed that cardiac
arrhythmia and increased stress have a positive relationship. While most authors
recommended more research in this area, all stated that women need
representation too.
As noted at this point in this literature review, the UK has a few recurrent
researchers interested in patient reaction to the lCD, such as Tagney and
Dunbar. Tagney (2003) had another work of a literature review published on the
subject. Some of her findings included that fear and anxiety relating to the
anticipation and unpredictable nature of the lCD shocks are common whether
patients had experienced a shock or not. She also found a link between adverse
psychological reactions and prospective predictors for occurrence of subsequent
arrhythmias and shocks. Another author who noted the relationship between
increased stress and increased risk of ventricular arrhythmias was Dunbar. She
reminds other researchers that persistent, negative emotions are associated with
increased serum levels of catecholamines, which result in vasoconstriction,
increased heart rate, and automaticity. This stimulates corticosteroids which
causes decreased healing and potentiates the effects of the catecholamines.
Hence, higher levels of psychological distress may affect health by increasing the
risk of cardiac arrhythmias (2005). Therefore, negative emotions may be a
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cause, not a consequence of arrhythmia events. Both Tagney and Dunbar noted
the need to further discuss women's issues.
Further in her literature review, Dunbar commented on the need for written
women's reactions to the lCD. She noted that being female is one factor
associated with increased psychological distress and reduced functioning. She
reported that, " ... the lCD takes on special meaning" (p. 295) for women in
relation to roles and concerns about childbearing and routine mammograms.
Compared to men, women have increased pain during recovery due to the
sensitivity of breast tissue and women's greater use of their arms in daily activity.
Another recent domestic literature review regarding anxiety and QOL of
patients with ICDs was done by researchers from the Mayo Clinic. Congruent
with previous study findings, Sola and Bostwick (2005) stressed the importance
of attending to the psychosocial issues of patients with ICDs. They justify this
caution since negative emotions are associated with increases in arrhythmias
and psychiatric illness can interfere with recovery from medical illness. These
researchers also stated inconclusiveness of gender-related susceptibility to lCD
induced psychopathology, with reason that subjects are mostly men. They
reported that some authors in their literature review suggest that women with
ICDs have an independent risk of developing mood disorders and experiencing
decreased QOL.
The three discussed studies questioned the idea of a relationship between
psychological problems and cardiac arrhythmias. All of these researchers
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addressed the lack of women subjects. Therefore, more research is needed to
further clarify these issues.
Evidence of Women-Specific Issues
The clinical effectiveness of the lCD has been well established for treating
patients with life threatening ventricular arrhythmias. However, as demonstrated
thus far, available research has mainly involved men. This phenomenon allows
for study findings to be generalized to all patients allowing for the unique health
concerns of women in this area to go misrepresented.
Depression and anxiety are a common finding in studies of patients'
reactions to lCD implantation. A quantitative study performed in Turkey which
aimed to evaluate the emotional status of patients with an lCD, indicated the
presence of depression and anxiety in nearly half of the sample. Subjects noted
that they had more limited lifestyles and 6% reported that they did not even leave
their homes after implantation. In females, depression and anxiety levels were
found significantly higher compared to males, with housewives having the
highest mean scores. Even though this study had an uneven amount of female
vs. male subjects (22: 79), the authors were able to suggest that female gender
was an independent predictor for increased anxiety scores (Bilge et al., 2006).
Other issues specific to women were pain and sleep. A study of 20 lCD
recipients performed in Sweden suggested that though sleep disturbances were
the greatest problem in both men and women, it was significant in women
(Carlsson, Olsson, & Hertevig, 2002). A more recent and domestic study of
gender differences in lCD insertion also asserted that women had more sleep
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difficulties than men. Since increased amounts of pain were noted in the female
subjects of this study, pain could be a factor in their difficulty in sleeping (Smith,
Dunbar, Valderrama, & Viswanathan, 2006).
Previously referenced researchers in this literature review performed yet
another study of patients' experiences of learning to live with an lCD. The UK
researchers conducted a qualitative, descriptive study using interviews of eight
patients; two female, six male. Though all experienced varying degrees of
psychological, social, and physical adjustment both pre- and post- lCD
implantation, some issues of pain and sleep were unique to female participants.
One woman in this study described continued pain from her sub-mammary
incision site which restricted her sleeping positions for six months after implant.
She was quoted as, "I was getting a pain under my shoulder blade. I can't lie with
this arm underneath my breast anymore" (p. 198). She also reported that due to
this, she had to restrict her bra type worn post implant, specifically no underwire
bras (Tagney, James, & Albarran, 2003).
A specific study on women with ICDs was completed in the United States
by Walker et al. regarding women's unique issues (2004 ). Researchers reported
that a woman's identity as a caretaker and caregiver might be threatened by the
actual and perceived activity limitations imposed by the lCD or the underlying
heart condition. They also found that both reproductive and sexual health are
important issues for women since 25-50% of female patients with ICDs reported
concerns in this area. Due to the emphasis on women's physical attractiveness,
body image was also of concern. The ICD's scar and lump in the pectoral area
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can become an issue. This is parallel to the previously discussed study where
one female subject reports that she thinks," ... one breast is higher than the other
now" (Tagney et al., 2003, p. 199).
Implanted cardioverter-defibrillator implantation does seem to pose unique
issues for women. Women share problems of anxiety and pain with men, but
sleep disturbances, body image, and reproductive health are specific to women.
There still seems to be an absence of complete, empirical, research data on the
impact of these concerns.

Theoretical Framework
The theory of unpleasant symptoms is an appropriate theory to guide
research on the experiences of women who live with an implantable cardioverter
defibrillator. As this literature review demonstrates, most patients living with this
device experience a variety of unpleasant symptoms. More specifically, research
shows women have many unique symptoms which could be treated more
efficiently if this theory was incorporated into their plan of care (Sears & Conti,
2006).
The middle range theory that fits this research project is the theory of
unpleasant symptoms (TOUS). The TOUS was formulated as a result of another
project, where two researchers, Drs. Linda Pugh and Audrey Gift were in the
process of defining management of two separate symptom models, fatigue and
dyspnea, when they noted similar models and interventions could be applied to
both symptoms with good results. The researchers realized that since their two
symptoms were so multiplicative, this relationship could be applied to other
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groups of symptoms as they occur in a dynamic clinical situation, thus the TOUS
was developed. The TOUS would provide nurses with one model to aid in
understanding and managing all unpleasant symptoms (Gift, 2004 ).
Since its development and after a revision in 1997, the TO US can be
found thoroughly used in research and in the clinical setting. Although not
conducted to test the theory, several published studies regarding other
symptoms such as nausea, pain, and additional gastrointestinal symptoms have
yielded findings consistent with the TOUS. Secondary analyses and subsequent
studies by the theory's developers and colleagues have contributed support by
relating it to fatigue during pregnancy, childbirth, and the postpartum period and
in dyspnea in patients with asthma and chronic obstructive pulmonary disease
(Lenz, Pugh, Milligan, Gift, & Suppe, 1997). The TOUS has performed well at
describing, predicting, and explaining similarities of the management of groups of
unpleasant symptoms.
Research has suggested that patients with an lCD experience a variety of
unpleasant symptoms (Sears & Conti, 2006). Therefore, utilizing this theory to
guide this research was appropriate. Using this theory in the care of women with
an lCD seems suitable as well since, if a nurse can tackle all or at least group the
symptoms together in order to treat with the same interventions, patients could
be managed more efficiently.
Although this study is qualitative in nature and so has no hypothesis,
primary, or secondary research questions, assumptions of results were still
made. According to research, all patients with an lCD experience some amount
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of depression and anxiety. However, symptoms of pain, difficulty sleeping, and
decreased quality of life are more significant in women than in men. Studies have
also shown that women with an lCD have issues specific to them like sexual and
reproductive health, body image, and changes in their perceived role as
caregiver (Sowell, Kuhl, Sears, Klodell & Conti, 2006). It was presumed
therefore, that this study would yield similar findings.
The TOUS concepts can be applied to this study in reference to prior
research results. As previously stated, the majority of studies show that women
must make psychological, social, and physical adjustments to their lCD. This is
congruent with the minor concepts under influencing factors of physiologic,
psychologic, and situational of the TOUS. These factors influence symptoms
which lead to consequences of the symptom experience (Lenz et al., 1997). This
reciprocal phenomenon has surfaced in research performed regarding women
with an lCD and was assumed to take place in the study.
In conclusion, the theory of unpleasant symptoms was an applicable
concept to guide the research study of the lived experiences of women with an
implantable cardioverter- defibrillator. Since women with an lCD encounter many
symptoms pre- and post-implantation, and immediately upon hospital discharge,
it can be assumed that these symptoms vary. However, with the help of the
TOUS, management and prediction of these unpleasant symptoms would
become more obvious.
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Chapter Ill
Methodology
This level one descriptive qualitative study examined the experiences of
women who live with an lCD. This chapter will provide an overview of the setting
and sample, methods, and procedures used in the study. Analysis and protection
of the human subjects are addressed and the incorporation of the theory of
unpleasant symptoms is provided.
Setting and Sample

The sample for this research study was attained from a cardiac clinic in
northern Florida. The clinic had 236 current lCD patients with 55 of them being
female at the time of data collection. Because qualitative samples are small in
size and sampling needs may change as the study progresses, it is important to
not incorporate too many participants at the onset of the study. Therefore, the
target population for this study was met with a purposeful, homogenous sample
consisting of the typical 15 participants used in a thematic analysis (Norwood,
2000). The inclusion criterion was adult, cognitively intact females who had the
lCD for less than three years. Exclusion criterion was patients awaiting discharge
from the hospital after implantation. In order to ensure participant comfort and
convenience, interviews were undertaken after follow up appointments in a
private room at the clinic and lasted no longer than 60 minutes.
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Procedure
Qualified women were invited into the study by telephone call by an
appointed staff member of the clinic who was familiar to them (See Appendix A).
After participants agreed to participate, the date, time, and place of the interview
were verified. A semi-structured interview schedule developed around the areas
of pre-implantation, immediate post-implantation, and discharge home was the
instrument used (See Appendix B). Open ended questions and prompts were
utilized to help elicit the unique experiences, beliefs, and attitudes of the women
subjects. In conjunction with the theory of unpleasant symptoms, various
complaints by the women were captured. After obtaining written informal
consent, the interviews were tape-recorded and then transcribed. Field notes
were kept in the case of participants giving further relevant information before
and after the taped interview.
Data Analysis
During data analysis, control and validity issues were addressed. In order
to maintain truth value, the researcher asserted that the study remained subjectoriented instead of researcher-imposed. Responses were carefully monitored by
maintaining a journal and debriefing with a colleague to ensure objectivity. In
order to declare external validity, the researcher strived for informational
adequacy and continued to perform careful data-analysis techniques. Fittingness
was granted once the researcher left a clear decision trail so that any reader can
follow the progression of the interview, understand the logic, and can arrive at the
same conclusions as the researcher in interpreting the data. The content of each
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transcription was independently analyzed in order to obtain the sense, meanings,
and context of the women's experiences. Selected quotes and textual passages
were assigned codes and then verified by the thesis chairperson in order to
validate analysis and interpretation of the participants' experiences (Norwood,
2000). This process allowed themes and categories to emerge. The
appropriateness of the theory of unpleasant symptoms as a framework for the
study then further surfaced.
Ethical Issues
Approval for the study was attained from the Mayo Clinic Institutional
Review Board (IRB) (See Appendix C) and from the University of North Florida
IRB (See Appendix D). Informed consent was required for all participants and
was retrieved just prior to the interview (See Appendix E). Also at the initiation of
the interviews, participants were briefed on the interview procedure and
reminded that they have the right to withdraw at any time and to refuse to answer
any of the questions. In order to maintain anonymity, all participants were
assigned and referred to as a lettered number. All of the recorded tapes were
destroyed once transcribed.
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Chapter IV
Results
Actual demographics for this study were comparable with the
researcher's anticipation. Twenty-four eligible women were contacted in order to
obtain the targeted number of 15 participants. Three women refused, two did not
return a phone call, three did not meet criteria, and one woman did not show for
her scheduled interview. All participants were currently receiving care at the
same clinic and all but three had their lCD implanted by the clinic's affiliated
electrophysiologists. Forty percent were inserted by a particular surgeon followed
by another who inserted 20% of the devices. Of the 15 participants, four had
received a high voltage, symptomatic shock. The majority or nine participants
were over 65 years of age (yoa); 27% were 79-83 yoa, 33% were 70-74 yoa, and
20% were 62-69 yoa, and 49-55 yoa respectively. The 15 participants were of
white race and maintained a mid- to upper socioeconomic status. All had their
devices for less than three years at the time of data collection. Forty percent had
lCD implantation three years ago, 33% had it two years ago, and 27% had it less
than two years before.
Five core themes emerged from the analysis of the women's transcriptions
along with multiple subcategories. The main themes include: Psychological
Reactions, Physical Comfort, Procedural Issues, Body Image, and Feelings
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Regarding a Shock. Discussion of the themes with examples of each are
provided next.
Psychological Reactions to the /CO

The narratives illustrate an overwhelmingly positive reaction to the
functions of the lCD. Psychological reactions derived mostly from the interview
question regarding the ICD's major effect on the participant's life. Eighty percent
of the participants made some sort of reference to feelings of reassurance of
having the lCD in case they need it and are the 12 participants discussed here.
Three of those 12 participants related the ICD's functions to the Emergency
Medical Service (EMS) surmising that the lCD is more efficient at defibrillation
since the lCD, " ... would take care of it (a cardiac arrest) immediately instead of
having to wait for some paramedic to come and do it'" and that, "It would be
better than 911." One participant referred to her lCD as her" ... own portable
device" and her own" ... life jacket" implying by the remainder of her discussion
that she feels secure with the lCD; an idea most of these 12 participants shared.
Half of the 12 participants referenced under this theme commented on that
idea of protection but actually say the words "safe" or "secure." For example,
one woman reported that the lCD " ... is my safeguard ... " while another stated,
" ... it makes me feel secure." One participant demonstrated strong conviction
regarding safety by her quote, "I am thinking that if anything goes wrong with my
heart, the thing will do its number and save me, so you can say I feel safer."
Satisfaction and reassurance were evident in several transcripts. One woman
who did not elaborate much except in this area of Psychological Reactions,
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reported that the lCD provided a" ... security of knowing it is there ... if something
happens, I got it." Yet, another participant was relieved to have her lCD since she
no longer felt she had to agonize over her risks of SCD reporting that " ... 1didn't
have to worry about whether I was having a heart attack every time I felt a twinge
somewhere ... ! just felt the most amazing sense of relief about that...! feel better."
Further positive Psychological Reactions were evident in the 12
participants' transcripts. Many viewed the lCD with a sense of assurance. Two
women quote the word "insurance" and go on to report that the lCD has already
saved their lives. One participant remembered exclaiming that she, " ... was going
to live!" after first receiving the recommendation for the lCD. Five in this group of

12 used favorable descriptions when commenting on their general reactions to
the lCD. Words like; "great," "wonderful," "excellent," "grateful," "very blessed,"
"awesome," "thankful," and "satisfying" dominated the majority of their narratives
regarding this theme. In general, most participants were, " ... glad to have it."
Multiple participants remarked on the technology of the lCD itself. Two
participants made references like, " ... the technology is here, it's awesome," and
"I think it is a great thing myself that you have something that can help you," and
"they can check you (she referenced lCD interrogations) and find out what is
going on ... that is very satisfying." Eight of the 12 participants implied that their
device was "smart."
While most of the 12 participants discussed under this theme verbalized
encouraging descriptions of Psychological Reactions to their lCD, some
demonstrated more neutral views. Along with commenting positively, 33% of the
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women also reported a lack of worry about the lCD and/or their health, and that
the lCD, " ... doesn't bother ... " them and that they "don't think about it." Many of
them implied that if the lCD was what they need, then that "is the way it is." One
participant gave mixed comments saying, "It really hasn't done much for me."
She however, went on to very casually say that the ICD's prevention of SCD is a
good thing and that" ... they are great evidently." Twenty-five percent of
participants expressed some doubt that their lCD would always help them;
quoted by one as, "I hope it lasts" and another hesitantly stated, "I guess I feel
more confident." Within this group of participants, it seemed that the longer the
participants had the lCD, the less positive comments they had regarding its
effects on their lives.
Physical Comfort

The core theme of Physical Comfort arose mostly from the interview
questions regarding immediate discharge home after implantation of the lCD.
Eighty-seven percent of women remarked in some noteworthy manner on
physical comfort from the implant whether it was immediate post operative or still
continues today. It is interesting to note that the three participants who had no
significant remarks regarding pain had their lCD implanted the furthest time ago,
had a harder time recalling events than the other 12, and were aged 70, 74, and
80 years.
Four of the 13 women referenced under this theme reported some degree
of immediate post operative discomfort. Three of those four stated intense
discomfort by recalling the pain as severe and lasting for an excessive amount of

33

time. Some of their stated feelings post operatively were; " ... really, really quite
painful,"" ... the pain was terrible," the pain," ... was the worst thing," and " ... it
lasted so long." One participant, a retired nurse, recalled her immediate
encounter with the pain as, "Honey, I had to lay down and keep still, just lay in
bed. I couldn't do anything. I couldn't have a conversation with you, it was so
bad." She was implanted three years previously, which suggests her experience
as intense as she recalled the events easily. It is interesting to note that the only
other nurse who participated in this study was also one of these four participants
who reported intense postoperative discomfort.
Some participants recalled specific reactions/occurrences immediately
post operatively, but with less negative emotion than described in the previous
paragraph. Two women reported that waking up after the surgery was not painful
and that the incision was not really uncomfortable. However, they both go on to
criticize the dressing of the incision, stating, " ... they put a pressure tape on the
area and it was cutting into me ... that was the only pain I was really having," and,
" ... it felt funny; all that gauze." One of those two women went on to say that she
did have some discomfort once the anesthesia wore off. She reported increased
discomfort from keeping her left arm on pillows in order to abide by the activity
restriction given to her as she recalled it.
Two participants voiced concern of addiction to the narcotic pain
medication prescribed upon discharge. One woman was so apprehensive that
she did not even fill her prescription, stating she " ... just took Tylenol." The other
convinced herself that the" ... discomfort could be in my head so I figured I am not
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going to get addicted to anything ... " She allowed her husband to dispense the
narcotic at his discretion as if to save her from becoming addicted.
Three study participants within this group described discomfort related to
the position or placement of the lCD post operatively and currently. Of interest is
that the most complaints related to this subcategory of position/placement were
from one of the three participants who had her lCD implanted by a non-clinic
affiliated physician. She recalls her initial discovery of the ICD's positional
discomfort and how it still feels today:
I could feel it rubbing against my collarbone ... It was painful and it hurt to
even lie down at night to sleep because of it rubbing on my collarbone. It
has shifted down a bit and I can put my thumb between the collarbone and
the lCD now ... If I were lifting something out of the closet I would have to
be careful because then it really shifts it back up again ...
She went on to report that she is used to it most of the time. In congruence with
this particular participant's discomfort while sleeping, two other women had
similar characterizations which were also in line with previous research (Tagney,
James, & Albarran, 2003). One woman described a pinching sensation when she
sleeps on her side and has to," ... get it [the lCD] just right." Another woman
depicted sleeping as, " ... if I lay on that side, I feel it and it kind of hurts ... l put
pillows on so there is not so much pressure but you are aware of it that way."
Thirty-one percent of the participants discussed in this Physical Comfort
theme depicted the lCD as not causing true pain, but more of a sensation of its
awareness. One participant reported that after one year of her implant, the
device itself remains somewhat sensitive. She worries about someone, "bumping
into it" and that she doesn't, "want anyone to hit it." Another woman who was
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very thin, stated that, "cold weather seems to bother mine ... when I'm cold, it
seems like it aches." All four mentioned that the seatbelt and/or their bra straps
currently irritate the lCD site, which is also congruent with previous research
(Tagney, James, & Albarran, 2003).
Twenty-three percent of the women depicted among this core theme
denied any physical distress related to their lCD. It is important to note that all of
these women had their devices implanted three years prior to their interviews and
reported no pain both immediate post operatively and today. One participant
compared her implant procedure to her open-heart surgery seven months prior
expectantly describing the lCD implantation as the "easier one." She stated she
is totally unaware of the lCD unless she physically touches it which then she
thinks, "Yes, I have this thing in me." Throughout her transcripts, she was
repeatedly quoted as saying, "It hasn't bothered me at all." Another participant
was in agreement with those ideals as demonstrated by her stating, "It doesn't
bother me a bit. In fact, I hardly know it is there sometimes. I feel it if I touch
myself but it doesn't ever give me any kind of feelings .... it has never bothered
me."
Procedural Issues
A third theme, Procedural Issues, emerged from the transcripts and
encompassed the highest number of comments. The interview schedule was
mainly composed of questions regarding pre and post lCD implant and discharge
home which explains this theme's size. Multiple subcategories surfaced mostly in
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the area of education and preparedness for lCD implant and will be discussed
next. All fifteen participants commented in this area and will be represented here.
Noteworthy discussion from participants' recollected thoughts upon first
hearing they needed the lCD transpired from 27% of the sample. None portrayed
any sense of alarm upon learning that they needed the lCD, which was
incongruent to other research (Bilge et al., 2006). In fact, the most negative
comment observed was, " ... well naturally I was a little apprehensive ... " However,
a counterbalance of her opinion was later made with," ... if that is what we
needed, then that is what we needed." The idea of doing just what the doctor
suggested was evident in all 27% of the participants discussed under this
subcategory. One woman who had just rehabilitated after open heart surgery and
had to have her lCD implanted emergently, stated, "I wasn't upset (when she
received the recommendation for the lCD) because I knew it wasn't anything to
worry about." Another participant described her recall of the recommendation as
threat-like stating, " ... he (the doctor) said you will not leave this hospital alive if
you do not have that (the lCD) .... so I said, alright, let's get with it!" Still another
seemed to let the physician take total control of her care as stating, "I would do
whatever he'd (the doctor) say. It's ok with me." One woman saw her ICD's
recommendation as more of a contract between her and her doctor as evidenced
by her statement, "He [the doctor] explained it to me. We agreed on it."
Six participants commented on the level of information given and amount
of preparedness they felt pre-operatively regarding the procedure itself. Most felt
they were well informed and possessed a sense of readiness. One participant
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was, "not nervous" because, "We (she and the nurses) had various educational
little summits ... They were very good about explaining things to me. If they
couldn't, they would get somebody who could ... l think I was well-informed."
Another woman commented on preparedness stating:
I was assured that I would be taken care of so I wasn't afraid. I had been
prepped in a sense of what was coming and what to expect. .. everything
was discussed ... literally, every minute I was told everything that was
happening. Actually, I was relaxed.
All six participants held the nurses responsible for their level of preparedness.
Even the woman, who had the most negative experience in the sample, had only
the nurses to thank for any information given. She describes her experience as:
No one talked to me much about what was going on ... I knew nothing
about the pacemaker before they put it in ... I think all along the line,
people assumed someone else was giving me the info and no one was
giving me the info. I didn't even know enough to ever ask the nurses ... the
last little nurse helped me so much, she would say, 'what don't you
understand?' ... I don't' understand anything! I don't know enough to ask
you any questions I told her.
Most participants used fond adjectives such as, "amazing," "reassuring,"
"wonderful," "very helpful," "impressionable," and "comforting" when describing
the pre-procedural nurses which is contrasting to a previous discussed study that
implied nurses were not confident in their ability to prepare lCD patients (Tagney,
2004).
Despite voicing adequate preparation, anxiety levels differed among half
of the participants. The woman who was post open-heart surgery stated that the
lCD procedure, " ... made me nervous initially." The two nurses in the sample both
expressed feelings of anxiety about the procedure and incidentally had the most
detailed recollection of the events. One described actually being placed in the
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holding area as, "I remember I was thin then and the table was very cold and
very hard, and they strapped me in which was pretty scary; you know because I
pretty much knew what was coming." The other reported, "I was scared to death.
I was very scared."
As previously indicated, most of the study's participants mentioned the
nurses from the clinic, holding area of the hospital, and/or hospital unit in their
transcriptions when questioned about procedural issues. Half of these
participants specified a particular nurse from the clinic as the person who
provided their education. One woman stated, "I love her. .. she was very, very
encouraging and just answered all of my questions ... she was actually better
than the doctor to a certain degree." Four women generalized nursing as an
important, helpful necessity during the lCD implantation. They viewed nursing
staff as reassuring, informative, and caring and seemed pleasantly surprised by
the degree of those characteristics. For example, one woman reported," ... there
are nurses out there I discovered that will give you the information you want."
Another stated, "You [nurses] don't realize what an impression you make on
people." Most participants mentioned a nurse at least once throughout their
interview; mostly without disclosure of his/her name.
The physician who implanted the majority of this sample's lCD, was
repeatedly referred to with high regards. He was described as, "an angel," "a rare
human being," "one of the most reassuring guys in the world," "such a caring
man," "wonderful," and "a good doctor." Two women reported that they would not
have had the lCD implanted unless he performed it, evidenced by statements
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like, "You know, nobody wants anyone but him." His demeanor and going "above
and beyond his call of duty" seemed to be at least some of the reason he has
such positive responses. For example, one participant's eyes seemed to light up
when she described how he personally telephoned her family and reassured
them, which later proved as very important to her. In fact, most of the women's
eyes lit up when speaking of him.
This man was not the only physician the participants spoke of. The
physician who implanted the next highest amount of ICOs was regarded by his
three patients but with more neutral connotations. He was referred to as, "ok" and
"very thorough." One participant, as implied previously, claimed that the nurses
were more informative than he. A different physician was regarded as,
"absolutely wonderful" by two of his patients in this study. The patient with the
thoroughly negative experience who was implanted by a physician affiliated with
another group, exhibited an attitude of betrayal by saying, "I just kept trusting
them ... those [the doctors] are the people you are supposed to be able to trust."
She goes on to say that once her care was transferred to the north Florida clinic,
she had answers and that she feels, "better than I have in two or three years."
Forty-seven percent of these participants grade their lCD implant
experience as generally positive. Most say that they have nothing bad to say
about the staff, hospital, or the clinic which is the reason given that they have
minimal recollection of the experience. Four participants state in some manner
that there was, " ... nothing alarming" about the incident and again, attributed that
to their forgetfulness. One reported, "I just remember being well taken care of ... it
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was just a sense of almost routine." All those who could not recall the procedure
were overly apologetic to the interviewer and seemed slightly embarrassed. They
all went on to say how much they love the clinic.
Upon exploration of immediate post procedural memories, three
participants discussed specifications about the wound itself. All expressed
apprehension regarding the incision with statements like, "I was afraid of looking"
and, "I had an incision and I know it is there, initially I was very frightened." One
participant recalled with observed disgust, frustration regarding the dressing of
the incision, "I couldn't get them to listen- to take off the tape because they kept
saying it had to be there. Consequently, I have a scar from where the tape was
cutting me ... " Others' recollections were less negative, just more of a sense of
acquiring an incision as demonstrated by, "I remember waking up pretty drowsy
and sore and I had this lump in my chest here (points to site)." Also, "I actually
felt that weight ... like I was carrying a bowling ball there ... " It seemed that after
criticizing the wound, participants made sure to conclude with a more positive
note. For instance, the lady who referred to the lCD as a bowling ball goes on to
say, " ... but that [the feeling] is gone. That dissipates with a little time." She also
states that she had "absolutely no problem with the wound." The lady recorded
as saying that she was afraid of looking at it later reported, "Then when I did look
at it the very first time after the second week, I thought, that's not your incisionthat's nothing! It really was nothing. It still is nothing." The participant who
complained of the scar from the dressing contradicts herself as," .... 1wasn't
really pleased ... but it heals."
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A final subcategory of Procedural Issues dealt with restrictions and
immediate discharge home. Thirty-three percent of the total sample expressed
opinions regarding driving. Two reported that it was more of an independence
issue, demonstrated by statements such as, "The horrible thing was that he (the
doctor) told me that I couldn't drive for six months. I just looked at him and said,
'six months!' I needed a friend to drive me around" and, "I just wanted to drive
again. I don't like being dependent on other people. It was a little frustrating ... "
They did convey understanding of the driving restriction exemplified by the
comment, "I certainly did not want to become unconscious should that device
kick in and cause an accident...! understood, but I didn't like it." Others
questioned what would happen if they were driving and the lCD delivered
therapy, which seemed to display ongoing concerns with driving but not as a
restriction per se. Still another participant stated that the driving restriction,
" ... was not a concern really."
Twenty percent of the participants under this theme of Procedural Issues
articulated concerns over immediate discharge home. Activity restriction was one
of those anxieties. One woman worried about taking a shower while another had
a hard time remembering to, " ... not reach behind or anything." She went on to
say that she was in disbelief over the lifting restriction of less than five pounds
exclaiming, "That's ridiculous! I can't even go to the grocery store! Sugar is a five
pound sack! Flour is a five pound sack!" Two participants expressed concern
over electrical considerations and the lCD. For example, they both stated that
they worried about going through security in the airport since now it would take a
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longer time and that they had to make sure they carried the correct paperwork
with them at all times. One woman said it was difficult at first to remember to use
her cell phone with the opposite hand from the side of the lCD.
Forty percent of the participants' narratives demonstrated a large amount
of anxiety upon immediate discharge home while two seemed to display an
amount of despair. One described the feeling as, " ... you go home and feel like,
am I going to be alright? Is this thing going to go off? What if I am driving?" The
other stated, "There was so much I didn't understand .... Should I not push the
vacuum cleaner? Should I not pick up my grandchild?" Still another stated with
less anguish, that she didn't understand but that she, "learned on the way."
Despite anxiety regarding immediate discharge home, 33% of participants
in the Procedural Issue theme were without apprehension. They stated that they
felt prepared and that the discharge instructions given to them in the hospital by
the nurses and the physician were easy to understand. They were well informed
and felt comfortable leaving the hospital especially since they knew the sequence
of events to come. Two of the women who had concerns over the driving
restriction closed with a positive note implying that the restriction was not forever
and that it worked itself out. All had at least one good thing to say about their
readiness for discharge home.
Body Image

Another core theme, Body Image, emerged from 53% of participants'
transcripts and will be discussed here. Summarizations with examples of those
eight particular women's narratives will be represented. These ideas emerged
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spontaneously since there was no specific question related to body image in the
interview schedule.
Sixty-three percent of the participants in this theme commented on size of
the lCD. Two women complained about its dimension but with a sense of
acceptance since their complaints were mostly from their initial sight of it postoperatively. For example, one woman reported," ... I was surprised how big it
was ... It was kind a funny having it, a big hump right there. It was awkward at
first." The other stated, "I wish it wouldn't be so big and ugly ... but there is nothing
you can do about that." The remaining three of the five participants discussed in
this paragraph used words like, "bulgy," "bulky," and that it "sticks way out" when
describing their ICD's appearance. In relation to how others see the lCD, one
woman remarked that," ... it still sticks out," and that," ... the kids go 'eww!' when
they see it." Another participant who seemed the most bothered by the lCD itself
stated, "It still sticks out a lot and I don't know if most people have a square box
on their chest." Her lCD was placed in an uncommon, elevated location on her
chest area due to her breast implants as reported by her.
Thirty-eight percent of the participants here portrayed issues related to
clothing after receiving their lCD. One woman joked that she would not be able to
wear a strapless dress, " ... but at 83 [years old], nobody would look anyway." She
went on to say that since others can always see her lCD, she is, " ... not going to
have a neckline (laughs) ... ! am too old for that kind of stuff." In contrast, another
woman declared, "The worst part is vanity ... so I changed necklines." A different
participant also used the word "vanity" as the only apprehension she had in
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regards to her ICD's appearance. Another woman did not alter any of her clothes
after her implant, stating, " ... little shirts, I wear them."
Half of the women discussed in this theme of Body Image actually stated
that they have not had any substantial reactions to their ICD's appearance. For
example, the woman who wished her lCD was not "so big and ugly" went on to
say that the way it looks, " ... doesn't bother me a bit in the world." The elderly
lady who joked about wearing strapless dresses described a relationship with her
lCD saying, " ... it's a part of me." Another woman said she can feel it with her
hands but doesn't notice it visually. The eldest participant in this study, 85 yoa,
said she changed, " ... absolutely nothing" about her clothing after receiving her
lCD implant. Though eight women mentioned something about body image
related to their lCD, it seemed that this theme was not as apparent as portrayed
in previous research (Sears, 2004; Tagney, James, & Albarran, 2003).

Feelings Regarding a Shock
The last theme that emerged from the narratives concerned 87% of
participants' thoughts about defibrillator shocks from the lCD. Of the 15 total
participants of this study, only 27% experienced an actual symptomatic shock
that they recall and/or were aware of. Subcategories such as; viewing a shock as
a warning, knowing what to do if it did happen, apprehension of an incoming
shock, along with the detailed occurrences from the four women who had the
shocks will be presented here.
Eight of the 13 participants who commented noteworthy on defibrillator
shocks saw them in a positive light. Many expressed feelings of gratitude that
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they had the lCD since if it shocked them; it was saving their lives. For example,
one woman reported, " ... I know if my heart stops, you know that is kind of a good
feeling that it would get kicked." Some shared the same idea that if they were
shocked, the lCD did "what it was supposed to do" and that it would be okay to
be shocked since then they would know it was working. Most saw the device as a
source of protection, similar to the subcategory under Psychological Reactions.
The participants also viewed a shock as a warning; that they had better
find out what they are doing incorrectly and change it. Thirty-one percent of the
women depicted in this theme expressed very similar theories as to why they
would ever receive a shock even though none had ever had one. For example,
they reported that if it shocked, then "something bad is going on" and they must
take initiative to change it since it is their responsibility. For example, one
woman's response to the interview question of "How do you feel about
defibrillator shocks from the lCD" is quoted as:
I would be concerned. Thankful. But I would be concerned that I needed to
change my diet, regulate pills better, or that I would have to do more ... I
would be concerned that it was telling me to 'fix something!' And then I
would have to search it down and find out what to do.
It is interesting to note that none of the women with this attitude had ever
experienced an actual lCD shock.
When asked what they would do if they ever experienced a shock, most
had someone in mind that they would call initially. One woman reported, " ... 1
would call family and get people here." Another said," I would call the doctor, my
daughter- I would call everybody." However, three women sought out validation
from the researcher that their plan was accurate. Two examples are, "I think that
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I would know to go and call the doctor- is that correct?" and " ... I would probably
call the doctor. I wouldn't know what else to do. I am assuming that is the
procedure? I don't know (looks at researcher for the answer)."
Thirty-one percent under the Shock theme voiced concern of where or
when a shock may take place. Two women expressed concern of receiving a
shock while driving. For example, they were quoted as, "My main concern with it
was, of course, if I happen to be driving ... you are going to be in trouble" and, " ... 1
wouldn't want to be driving and cause somebody to get hurt." Even though they
communicated concerns of being shocked while driving, none drove any less.
One woman uttered concerns of what she might do to facilitate a shock and if
she was out in public, "Is this going to jolt me and right in the middle of work or
right in the middle of church, and what's going to happen?" Along the same idea,
another woman, who had received a shock stated, " ... I think, oh God, I don't
know if I should be doing this, but mostly when it (raises her arms) is over my
head ... so I think about it then. Then I think, oh if this thing ever went off, but
that's all." Two ladies reported that even though they sometimes think about
ongoing limitations, the thought of an lCD shock does not restrict their activities;
summed up by one woman as, "It won't keep me from doing anything. I swim and
do everything."
Whether these 13 participants experienced an actual shock or not, all
voiced at least a small amount of apprehension regarding one. Statements like,
"It would make me nervous," "I would freak out," and "I would panic probably"
dominated the narratives in regards to initial reactions to a shock. One woman
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verified her feelings of anxiety towards a shock by saying, "I don't think I would
enjoy the feeling of the pain being so great it would drive me to my knees."
Another participant stated that apprehension of a shock, "was one of my worries."
Three women stated that they hope the lCD "never goes off," however one of
those three who had had a shock expressed that idea with much more conviction
by exclaiming, "I hope to hell that it never goes off!" She later goes on to say that
she thinks about it shocking her again, "once in a while." Another woman
commented on being shocked again as, "It would be like having an experience of
being in an automobile accident and going back driving an automobile and it
would come back."
Though multiple participants expressed apprehension regarding an lCD
shock, most went on to also say that they do not continuously think about it. Four
women stated that the thought of a shock does not bother them and/or they do
not worry about it. The lady that compared her recollection of her shock to an
automobile accident reports that that memory," ... gets less as time heals."
Another woman who also experienced a shock reported that the fear of another
one, " .. .finally faded after I guess about four months." The lady that reported she
would initially panic if she was shocked says she wouldn't panic as much now
since she has received more education regarding its proposed feeling.
As previously stated, 27% of participants experienced an actual
symptomatic defibrillation. One woman had little to say regarding its feeling, even
after much prompting. Her only statement was," ... it got me back on track."
Another woman had a better detail of the experience as it happened on her way
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to the dining room of her assisted living facility. A shock was delivered yet she
still continued to enter the room as described by her as, " ... Oh God, I sort of felt,
all of a sudden, a sharp pain ... so I sat down ... I said [to her son] I'm fine. So in
we went [to the dining area] and that was it." She reported later that the shock,
"didn't hurt," and that, "It wasn't any great shock. It was just a little one," and,
" ... that's the only time it's ever done it. I'm still hoping it never goes off again."
A different woman received multiple shocks from her lCD. She reported
the experience as traumatic since she had one episode where her lCD went off
three times in ten minutes. She reported that," ... it takes your breath away." She
was quoted as saying, "somebody described it to me like being kicked in the
chest by a mule ... it's more like being kicked in the chest by an elephant.. .pretty
scary experience." She goes on to say that that the lCD did what it was
supposed to do and that it," ... was not the end of the world." Despite her
seemingly appreciation for the shock, she admitted that she, "toys with the idea
of turning it off."
The last woman in this study with a history of lCD shocks had a more
detailed recollection of the experience. She described it as a frightening,
horrifying, distressing, and traumatizing event. She was quoted as:
I woke up and this thing went- JOLT! Of course, you jump a mile! It is sort
of like an electrical shock. I can't describe it really. And then it was at
intervals. It would shock me and then maybe in 15 minutes, it would do it
again, and again, and again. And that is frightening!
She went on to illustrate that though the physical feeling was horrible, the
psychological sensation of not knowing what to do and others around her feeling
scared was just as dreadful. For example, she recollected the incident as, " ... but
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it is a very frightening experience and it's because you don't know what's
happening .... and that was more so because the people around me didn't know
either." She repeatedly mentioned that her husband could feel the shocks when
putting his hands on her for comfort which she conveyed as very bothersome to
her. She stated she finally felt some relief upon arrival to the hospital but that she
remembers the event very vividly.
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Chapter V
Discussion
Health care providers can utilize the documented experiences of women
who live with an lCD from this study to better prepare and help manage concerns
of these patients pre- and post-implantation. Acknowledging that there are needs
specific to women who have an lCD is important to nursing practice and to any
female patient's coping mechanism. Responding to concerns regarding lCD
implantation is relevant specifically to nursing since nurses prepare patients for
the experience and are often the first to hear of patients' unpleasant symptoms.
The Theory of Unpleasant Symptoms
In the theory of unpleasant symptoms (TOUS), three categories of
variables are recognized: Physiologic Factors, Psychologic Factors, and
Situational Factors. Within each category, several interrelated aspects should be
considered and can be applied to multiple scenarios. All of the aspects relate to
one another and may interact to influence the symptom experience (Gift, 2004).
The five core themes that emerged from this research can be divided into these
three categories and will be discussed next.
Physiological Factors
Physiological Factors as explained by the TOUS are multiplicative.
Examples are: normally functioning bodily symptoms, existence of any pathology,
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trauma occurrence, and level of energy. The core theme of Physical Comfort can
be categorized here. Any operation can be regarded as a type of trauma as does
the surgical insertion of an lCD. Women's voiced concerns of pain post
operatively provide for an example of a normally functioning bodily symptom. The
women under this theme experienced pain in the incision itself and/or
generalized discomfort immediate post surgery and some today. It is possible
that pain can increase the intensity of other symptoms as in the case of one
patient who reported that due to her pain, she experienced decreased levels of
energy which also qualifies as an aspect in the Physiological Factor group.
Another theme from the research that could be applicable under
Physiological Factors of the TOUS is; Feelings Regarding a Shock. When
describing the actual sensation of defibrillation from the device, all women
described it at least as uncomfortable. Most comments were of more intense
descriptions. The physical feeling of a shock can be classified into this category
since again, pain can intensify other symptoms.
Psychological Factors
Many women from the study experienced aspects of the Psychologic
Factors category and was an area of focus from two different core themes. The
first, Procedural Issues, supplied examples of mental states and mood. For
example, six participants commented on the level of information given, amount of
preparedness, and subsequently, their mental state before their lCD insertion
with anxiety. The degree of uncertainty, or mood was observed when the women
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expanded on their appreciation of the nurses' education regarding the lCD
insertion procedure.
Another core theme of Body Image fits into this category of Psychological
Factors. Many women saw the ICO's size post procedure as negative which
could be classified as an ineffective response to it as the TOUS explains. The
reaction to the incision and ensuing scar was demonstrated as unconstructive in
33% of the sample. Other participants stated they had no substantial reactions to
the appearance of the device or its scar, which in contrast, could be labeled as
an effective response which would not intensify the degree of any other
symptoms.
Situational Factors
The core theme, Psychological Reactions can be listed in the third and
last category of the TOUS, Situational Factors. The fact that the majority of the
sample were of middle to high socioeconomic status and possessed functioning
support groups could have affected their lived experiences. All participants had
direct, easy access to health care and its resources. Only one member of the
sample was overweight; the others took pride in remaining active. These
situational factors could have influenced the way they perceived their symptoms.
Limitations to the Study
There were multiple limitations to this study. The sample demographics
could arguably provide for biases. The setting of the interview may have had an
impact on the answers given by participants. Reasons the patients qualified for
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the lCD were varied. The rapport established between participant and researcher
could have played a role on responses given by the women.
Study participants lacked diversity possibly contributing to bias. All women
were of white race, over the age of 49, and of mid to high socioeconomic status.
Inclusion of younger women and of a lower socioeconomic status may have
provided a more complete representation of the female population receiving lCD
implantation.
The majority of the sample received the lCD only as prophylaxis with a
needed bi-ventricular pacemaker to aid alleviation of symptoms of heart failure,
not exclusively for treatment of survivors of SCD as the researcher had strived
for. Therefore, many women's responses to interview questions pertained to the
improvement the pacemaker made on their chronic illness symptoms, not of the
shock itself; evident by only 27% of participants ever actually receiving a shock.
Some women even referred to their lCD as a pacemaker, not an lCD. However,
the majority of the sample was able to demonstrate the distinction if specifically
questioned.
The clinic where the sample was collected has a reputation for striving for
excellence in education, research, and patient care. All of the participants were
currently under the care of this clinic and all portrayed a sense of pride in such.
With that being said, receiving preparation, care, and membership at such a
renowned institution brings much positivity to the overall opinions of its members.
For example, every participant made at least one encouraging remark about the
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clinic; most supplied multiple comments. Patients from random institutions may
have allowed different views on their experiences.
The setting of the interview may have interfered with some patients'
remarks to questions. All participants' interviews took place directly after a followup appointment possibly contributing to melancholy which may have influenced
their answers. Some of the patients did receive grim news regarding their
prognosis just prior to the interview. For example, one woman was
recommended placement on the heart transplant list a few minutes before her
interview. Another was in the midst of heart failure exacerbation while being
questioned. It could be argued that the mere showing up for the appointment is a
reminder of inevitable mortality. This may have guided their answers in that
multiple members of the sample did not think the lCD was really helping them.
Answers to the interview schedule could have been swayed by the choice
of methodology used in the study. The researcher's inexperience in interviewing
and amount of rapport established could have played a role in how much
information the participants provided. Thankfully, the sample was probably large
enough to account for this possibility. The researcher's comfort with and
fondness of elderly women probably worked to her advantage and as a
counterpart to her inexperience as an interviewer. However, it still deserves
mentioning as a limitation since the entire sample was not elderly. Also, in
congruence with self-report research, answers to interview questions may have
been influenced by characteristics of how the participant thought she should
respond and how she wanted to be perceived.
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Implications for Nursing Practice

The personal thoughts, opinions, and impressions given by the 15
participants in this study allow for multiple suggestions to practicing nurses. An
awareness that some of the women displayed was how much knowledge nurses
actually possess. Therefore, study results could encourage nurses to take a
stand for what they know and not be reluctant to share with patients. More than
any other health care professional, nurses focus on the impact a
disease/condition has on the daily lives of patients and are therefore in the front
line in all aspects of lCD implantation. Nurses educate, offer support, and provide
both physical and mental comfort throughout patients' experiences.
Many participants appeared to respond better to the nurses than the
physicians especially immediate post-implant. Since lCD implantation is an
overnight stay in a hospital, staff nurses are given an ample opportunity to
educate, reinforce, and prepare patients for the immediate discharge home.
Patients from this institution do receive much education though a lack of
understanding and/or recollection of it was apparent in some transcriptions. More
or repetition of the pre-procedural teaching with a focus on gender should be
instilled.
With regards to discharge home, nurses could serve to continue education
and allow for support. For example, a follow-up phone call to all recipients from a
nurse may provide assistance and encouragement. Nurses should stay abreast
of support groups and promote their use. Support groups are available yet, are
not always taken advantage of especially by women. The option of online
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international forums should also be encouraged. One such online blog is The
Zapper (www.zaplife.org) which provides nonprofit information sessions and
individual postings. Witnessing that many of the entries from this site's chat room
were made from women, creation of women-specific support groups, whether
online or in person may be beneficial.
Several important implications from this study become apparent for the
Advanced Registered Nurse Practitioner (NP). The majority of NPs practice in
the primary care setting where most chronic disease conditions are managed.
Being knowledgeable about sudden cardiac death, cardiac arrhythmias, and
subsequent treatment with an lCD, will ensure better assessment of patient
status. It is important for NPs to understand the latest treatment options available
and how to manage the care of a patient who has a unique device like an lCD.
They should stay abreast of how it operates, follow up schedules with the
cardiology staff, and the option to disable the lCD when the time comes. It is
important not only that NPs have the ability to explain to their female patients
how an lCD works and how it is inserted, but now with information from this
study, be able to report what the experiences of living with an lCD is like from a
female patient's perspective.
Once the NP is aware of her patient's plan to receive an lCD, she could
take part in its preparation on regular visits. She might discuss pain medications
and encourage the patient to ask the electrophysiologist for a type of pain
medication that has worked for her in the past. Since a few participants
expressed concern over narcotic addiction, she should mention the need and
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proper use of pain medication making sure to also speak directly to the family as
to help alleviate fear and uncertainty. Most participants had issues with the
incision itself and the ICD's size and weight, therefore the NP should reiterate
realistic expectations.
Immediate discharge home was an issue with many of the women in this
study. The NP is in a position to educate and reinforce driving and activity
restrictions, making sure to use layman's terms. She could clarify specific actions
to do or not do as participants articulated in the study such as specific household
duties, church attending, and handling grandchildren and pets. Promotion of
involvement of their support systems in their presence since many women
shared the idea of "burdening" others should be accomplished at these visits.
Since multiple participants conveyed doubt during the interviews on what to do if
shocked, the NP should encourage development of a specific plan if the lCD
administered therapy and continue to remind them and update it on subsequent
visits.
Considering how much female patients revere nurses and all they have to
offer, staff nurses should encourage support groups and discussion with their NP
about their lCD at the time of hospital discharge home. Since many participants
in this study demonstrated positive psychological responses to the lCD, the NP
should encourage and nurture those feelings. However, the NP should not
discourage expression of pessimistic feelings regarding the lCD. As suggested in
this study, some patients seemed less enthusiastic as time progressed, so NPs
could periodically remind them of the ICD's functions. Counseling and coping
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support should be offered at every office visit. She should be realistic and
support any decision or exploration of patients' thoughts of disabling the lCD also
at any time.
Implications for Future Research

Further research is warranted to bring awareness to the experiences of
women who live with an lCD. Few studies here in the US have been conducted
using a large sample of women specifically on reactions to the lCD. This study
adds to the research that has identified some unique issues specific to women
with an lCD. More research can only strengthen these findings and educate
healthcare professionals regarding these gender specific issues of living with an
lCD.
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Appendix A
Topic of Telephone Script:
This telephone script will be used to recruit participants into the study.

Introduction:
"Hello, this is Jennifer Crain calling from the Mayo Clinic in Jacksonville. May I
please speak to _ _ _ _ _ _ _ _ _ _ _?"

***If the person is there, continue with the script.
***If the person is not there, ask when it would be a good time to call to speak
with
?

Describe the Reason for the Call:
(Example of phone call to potential participant)
I am calling to invite you into a research study we are conducting to help us learn
about the experiences of women who live with an /CO. Please understand that
your current or future medical care at the Mayo Clinic will not be jeopardized if
you choose not to participate. Is this something you would be interested in
gaining more information about?
If no: Thank them for their time and stop the recruitment process.
If yes: The primary investigator, Jenea Smith is a UNF graduate student in the
Nurse Practitioner Program. She is going to perform one interview with you
where she will ask you questions about your experiences related to your /CO.
The interview will last no more than 30 to 60 minutes and will take place at the
Pacer Clinic. Once you agree to participate, I will set up an interview date and
time. Of course, whenever possible, I will schedule your interview around the
time of your next follow-up appointment. Would you like to participate?
***If questions: Answer questions in order to clarify interview process only.
***If no questions and in agreement to participate: verify date, time, and place of
interview. Thank you for participating in our research study. Please understand
that your answers will remain confidential. Good-bye.
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Appendix B
Interview Schedule
DATE IMPLANTED: _ _ _ __

PARTICIPANT AGE: _ _
TIME START: _ _ _ __

TIME END _ __
Pre-implantation of lCD

1. Can you tell me what you remember of the events leading up to you having the lCD
implanted?
PROMPTS:
-Specific/related hospital admission
-How do you feel about this?
Post-implantation of lCD
2. What particular concerns did you have at the time before leaving the hospital?
3. In what ways were you prepared for discharge home?
PROMPTS:
-Any suggestions to nurses who educated you?
Discharge home
4. Think back to when you were first discharged home after implantation of the lCD, how did
you personally cope during those first few weeks?
5. What do you recall as your immediate practical concerns at that time?
6. Overall, what would you say have been the major effects that having lCD has had on
you?
lCD shocks
7. How do you feel about defibrillator shocks from the lCD?
PROMPTS:
-Have you experienced one?
-How do you think it would affect you?

61

Appendix C
Mayo I RB Approval
Principal Investigator Notification:
From: IRB
To:
Jenea Smith

CC:

Study Team Members that are marked as wishing to receive correspondence
regarding the protocol/grant application

Re:

Application# 07-004210
Click the link below to access the protocol/grant application information in
your IRBe workspace, as well as the approved consent document(s)/Rough
Word consent
document(s) that need to be used when submitting consent changes as
part of a modifications request (if applicable) under the Documents tab:
07-004210

Please note that all correspondence (modifications, progress reports, reportable
events) related to this study/grant application must be submitted electronically in the
IRBe system.
The following is a REVISED excerpt from the minutes of the Expedited Review A of the
Mayo Clinic Institutional Review Boards meeting dated 7/17/2007:
The Committee reviewed and approved for human studies the protocol entitled "The
Lived Experiences of Women with an Implantable Cardioverter Defibrillator (lCD)." from
Ms. Jenea Mary Smith. The Committee noted that the human studies aspects involve
an audio taped interview of female subjects who have had their implantable cardioverter
defibrillator less than three years. A maximum of 15 adult female participants with an
lCD are approved for enrollment in this protocol at Mayo Clinic Jacksonville. Due to
participant contact, written HIPAA authorization and informed verbal consent (which is
obtained by participants completing the interview) must be obtained. Documentation of
verbal consent (as a CEN) and a scanned HIPAA form should be placed in each
participant's medical record. The telephone script and interview schedule were
approved as written. The HIPAA Authorization form was approved with revisions. The
IRB office will provide the final approved form on the IRBe workspace for this item. The
Committee determined that this constitutes minimal risk research, and therefore was
eligible for expedited review in accordance with 45 CFR 46.11 O(b )(1) and 63 FR 60364,
item 6. This approval is valid for exactly one year unless during the year the IRB
determines that it is appropriate to halt or suspend the study earlier. 07-004210
Tremaine. William J. M.D. , Chair
Gina Dahlgren , Specialist
Mayo Clinic Institutional Review Boards

Expedited Review A
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Appendix D
UNF IRB Approval

UNIVERSITY of
NORTH FLORIDA.
Office of Research and Sponsored Programs
I UNF Diive
Jacksonville, FL 32224-2665
904-620-2455 FAX 904-620-2457
Equal Opportunity/Equal Access/Affirmative Action Institution

MEMORANDUM
DATE:

September 11, 2007

TO:

Jenea Smith

VIA:

Dr. Lillia Loriz,
Nursing

FROM:

Dr. David Kline, Chair
UNF Institutional Review Board

RE:

Review by the UNF Institutional Review Board IRB#07-110:
"The Lived Experiences of Women with an Implantable Cardioverter
Defibrillator (ICD)"

This is to advise you that your project, "The Lived Experiences of Women with an
Implantable Cardioverter Defibrillator (ICD)," has been reviewed on behalf of the UNF
Institutional Review Board and has been declared exempt from fmiher IRB review.
This approval applies to your project in the form and content as submitted to the IRB for
review. Any variations or modifications to the approved protocol and/or informed
consent fotms as they relate to dealing with human subjects must be cleared with the IRB
prior to implementing such changes.
Should you have any questions regarding your exemption or any other IRB issues, please
contact Nicole Sayers, Assistant Director of Research Integrity, at 620-2498.
Thank you.
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Appendix E
Consent Form

c{9J MAYO CLINIC
Authorization to Use and Disclose
Protected Health Information
TTTl.E

IRB#

"The lived Experiences of Women with an Implantable Cardioverter Defibrillator {ICDl"

07-€104210

.I July 24, 2007

RESEARCHER

PROTOCOL:t:AST APPROVED BY IRB

Ms. Jenea Smith

THIS FORM APPROVED

July 24, 2007

Your privacy is important to us, and we want to protect it as much as possible. By signing this funn, you authorize
Mayo Clinic and the investigators to use and disclose any information created or collected in the course of your
participation in this research protocol. This information might be in different places, including your original
medicru record, but we will only disclose information that is.related to this research protocol for the purposes listed
below.

This information wlll be given out for the proper monitoring of the study, checking the accuracy of study data,
analyzing the study data. and other purposes necessary for the proper conduct and reporting of this study. If some
of the information is reported in published medical journals or scientific discussions, it will be done in a way that
does not directly identify you.
This information may be given to other researchers in this or private, state or federal government parties or
regulatory authorities (U.S. and other countries) responsible for overseeing this research. These may include the
Office for Human Research Protections, or other offices within the Department of Health and Human Services, and
the Mayo Clinic Office for Human Research Protections or other Mayo groups involved in protecting research
subjects.
If this information is given out to anyone outside of Mayo, the information may no longer be protected by federal
privacy regulations and may be given out by the person or entity that receives the information. However, Mayo will
take steps to help other parties understand the need to keep this information confidential.
This authorization lastl; until the end of the stud~.
The study does not end until all data have been collected, checked (or audited) and analyzed. Sometimes this can be
years after your study visits have ended.
You may stop this authorization at any time by writing to the following. address:
Mayo Clinic
Office for Human Research Protection
ATIN: Notice ofRevocation of Authorl211tion
200 lst Street SW
Rochester, MN 55905

If you stop authorization, Mayo may continue to use your information already collected as part of this study, but
will not collect any new information.

UNIF ORB Number.

0}.- ( {c>

,Appmvat Date:
Revtsion Pate:

IRB 07-004210

Form not to be used after July 23, 2000
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